Downloads provided by UsageCounts
This document describes the data access request procedure for the Amyloid Imaging to Prevent Alzheimer’s Disease (AMYPAD) Prognostic and Natural History Study (PNHS). Those researchers interested in using the integrated AMYPAD PNHS dataset can request access to the imaging, clinical, and biomarker data for scientific research investigation and/or educational activities. The application can be performed via the FAIR Data Service of the Alzheimer’s Disease Data Initiative (ADDI).
AMYPAD PNHS is registered at www.clinicaltrialsregister.eu with the EudraCT Number: 2018-002277-22. The AMYPAD project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 115952. This Joint Undertaking received support from the European Union's Horizon 2020 research and innovation programme and EFPIA.
Cognition, AMYPAD, Dementia, Neuroimaging, Alzheimer's disease, Biomarkers
Cognition, AMYPAD, Dementia, Neuroimaging, Alzheimer's disease, Biomarkers
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
| views | 164 | |
| downloads | 105 |

Views provided by UsageCounts
Downloads provided by UsageCounts